ADVERTISEMENT
Opinion: Emergency Use Authorizations Are a Threat to Science<strong>&nbsp;</strong>
Opinion: Emergency Use Authorizations Are a Threat to Science 
As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.
Opinion: Emergency Use Authorizations Are a Threat to Science 
Opinion: Emergency Use Authorizations Are a Threat to Science 

As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.

As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.

disease & medicine, clinical trials, drug development, regulation

A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Jef Akst | Oct 8, 2020 | 9 min read
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
tamiflu
Updated Review: Tamiflu Is a Bust
Kerry Grens | Apr 10, 2014 | 2 min read
After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.
ADVERTISEMENT